Vident Investment Advisory, LLC Biogen Inc. Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $2.2 Million - $2.54 Million	-7,997 Reduced 58.84%	5,594 $1.59 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $1.22 Million - $1.39 Million	4,751 Added 53.74%	13,591 $3.78 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $623,274 - $757,291	2,469 Added 38.75%	8,840 $2.45 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $209,681 - $289,131	1,077 Added 20.34%	6,371 $1.62 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $7.37 Million - $8.76 Million	-39,291 Reduced 88.13%	5,294 $1.07 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $1.72 Million - $2.16 Million	8,854 Added 24.78%	44,585 $9.39 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $2.05 Million - $2.64 Million	9,168 Added 34.51%	35,731 $8.57 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $1.01 Million - $1.32 Million	-3,583 Reduced 11.89%	26,563 $7.52 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $491,064 - $786,290	-1,896 Reduced 5.92%	30,146 $10.4 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $1.94 Million - $2.27 Million	7,992 Added 33.23%	32,042 $8.96 Million
Q4 2020 Feb 08, 2021	BUY	$236.26 - $355.63 $743,746 - $1.12 Million	3,148 Added 15.06%	24,050 $5.89 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $682,841 - $788,426	2,579 Added 14.08%	20,902 $5.93 Million
Q2 2020 Jul 17, 2020	SELL	$258.66 - $342.55 $582,502 - $771,422	-2,252 Reduced 10.95%	18,323 $4.9 Million
Q1 2020 May 12, 2020	BUY	$268.85 - $341.04 $680,728 - $863,513	2,532 Added 14.03%	20,575 $6.51 Million
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $2.59 Million - $3.58 Million	11,787 Added 188.41%	18,043 $5.35 Million
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $337,901 - $378,989	1,554 Added 33.05%	6,256 $1.46 Million
Q2 2019 Aug 12, 2019	BUY	$219.29 - $241.72 $755,234 - $832,483	3,444 Added 273.77%	4,702 $1.1 Million
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $283,023 - $442,681	-1,306 Reduced 50.94%	1,258 $297,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $74,081 - $93,831	266 Added 11.58%	2,564 $772,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $170,529 - $223,005	581 Added 33.84%	2,298 $812,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $190,307 - $226,806	739 Added 75.56%	1,717 $499,000
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $289,004 - $408,748	-1,111 Reduced 53.18%	978 $259,000
Q4 2017 Feb 15, 2018	BUY	$307.64 - $344.58 $339,634 - $380,416	1,104 Added 112.08%	2,089 $665,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $276,932 - $324,744	985	985 $308,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account